Evidence map›Paper›PMID 41079938›Full record

ArticleInternational journal of biological sciences2025

Neutrophil Recruitment via Hepatocyte IL-1α Drives NETs-Mediated AIM2 Hepatocyte Apoptosis in Alcohol-associated steatohepatitis.

Yuan Zhang, Xueteng Meng, Yan Ding, Jinmao Yu, Yunyun Wan, Zhiying Yang, Zheyu Han, Qian Zhu, Rui Feng, Jun Li and 2 more

Abstract read
In one paragraph

Article in International journal of biological sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yuan ZhangInflammation and Immune Mediated Diseases Laboratory of Anhui Province; Anhui Institute of Innovative Drugs; School of Pharmacy, Anhui Medical University, Hefei 230032, Anhui, China.
Xueteng MengInflammation and Immune Mediated Diseases Laboratory of Anhui Province; Anhui Institute of Innovative Drugs; School of Pharmacy, Anhui Medical University, Hefei 230032, Anhui, China.
Yan DingInflammation and Immune Mediated Diseases Laboratory of Anhui Province; Anhui Institute of Innovative Drugs; School of Pharmacy, Anhui Medical University, Hefei 230032, Anhui, China.
Jinmao YuInflammation and Immune Mediated Diseases Laboratory of Anhui Province; Anhui Institute of Innovative Drugs; School of Pharmacy, Anhui Medical University, Hefei 230032, Anhui, China.
Yunyun WanInflammation and Immune Mediated Diseases Laboratory of Anhui Province; Anhui Institute of Innovative Drugs; School of Pharmacy, Anhui Medical University, Hefei 230032, Anhui, China.
Zhiying YangInflammation and Immune Mediated Diseases Laboratory of Anhui Province; Anhui Institute of Innovative Drugs; School of Pharmacy, Anhui Medical University, Hefei 230032, Anhui, China.
Zheyu HanInflammation and Immune Mediated Diseases Laboratory of Anhui Province; Anhui Institute of Innovative Drugs; School of Pharmacy, Anhui Medical University, Hefei 230032, Anhui, China.
Qian ZhuInflammation and Immune Mediated Diseases Laboratory of Anhui Province; Anhui Institute of Innovative Drugs; School of Pharmacy, Anhui Medical University, Hefei 230032, Anhui, China.
Rui FengInflammation and Immune Mediated Diseases Laboratory of Anhui Province; Anhui Institute of Innovative Drugs; School of Pharmacy, Anhui Medical University, Hefei 230032, Anhui, China.
Jun LiInflammation and Immune Mediated Diseases Laboratory of Anhui Province; Anhui Institute of Innovative Drugs; School of Pharmacy, Anhui Medical University, Hefei 230032, Anhui, China.
Cheng HuangInflammation and Immune Mediated Diseases Laboratory of Anhui Province; Anhui Institute of Innovative Drugs; School of Pharmacy, Anhui Medical University, Hefei 230032, Anhui, China.
Taotao MaInflammation and Immune Mediated Diseases Laboratory of Anhui Province; Anhui Institute of Innovative Drugs; School of Pharmacy, Anhui Medical University, Hefei 230032, Anhui, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alcohol-associated steatohepatitis (ASH) represents a critical stage in the progression of Alcohol-associated liver disease (ALD), characterized by extensive hepatocellular steatosis, immune cell infiltration, and a poor therapeutic response. Neutrophils play a central role in the inflammatory landscape of ASH, with their hepatic accumulation strongly correlating with disease severity. Although studies have demonstrated that neutrophil depletion attenuates liver injury, the precise mechanisms underlying neutrophil-mediated hepatocellular damage remain poorly defined. Neutrophil extracellular traps (NETs), web-like DNA structures released during NETosis, have emerged as key effectors in sterile inflammation and may exacerbate liver injury beyond their antimicrobial functions. In this study, we employed the Binge-Gao mouse model to explore the involvement of NETs in ethanol-induced liver injury. Our findings revealed that ethanol exposure led to significant hepatic neutrophil infiltration and NET formation. Stressed hepatocytes released damage-associated molecular patterns (DAMPs), particularly interleukin-1 alpha (IL-1α), which activated Toll-like receptor 9 (TLR9) on neutrophils, thereby enhancing NET generation. NET components subsequently activated the cytosolic DNA sensor AIM2 (absent in melanoma 2) in hepatocytes, triggering apoptosis. This cascade illustrates a previously unrecognized immune axis linking ethanol-damaged hepatocytes, NET-producing neutrophils, and DNA-sensing death pathways.

Indexed as

DNA-Binding ProteinsExtracellular TrapsFatty Liver, AlcoholicHepatocytesInterleukin-1alphaNeutrophil InfiltrationAnimalsApoptosisEthanolMaleMiceMice, Inbred C57BLNeutrophilsToll-Like Receptor 9Aim2 protein, mouseDNA-Binding ProteinsEthanolInterleukin-1alphaToll-Like Receptor 9AIM2alcohol-associated steatohepatitisapoptosisIL 1αneutrophil extracellular traps

Identifiers

PMID41079938
PMCPMC12509912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.